Iman Osman

Interdisciplinary Melanoma Cooperative Group, Perlmutter Cancer Center

Affiliated withPerlmutter Cancer Center NYU Grossman School of Medicine

Research Area

Biography

Iman Osman has not added Biography.
If you are Iman Osman and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 2	2022

Other Publications

Article	Year
Melanoma expression of matrix metalloproteinase-23 is associated with blunted tumor immunity and poor responses to immunotherapy. Journal of translational medicine\| PubMed ID: 25491880	2014
RSK1 activation promotes invasion in nodular melanoma. The American journal of pathology\| PubMed ID: 25579842	2015
Genetic associations of the interleukin locus at 1q32.1 with clinical outcomes of cutaneous melanoma. Journal of medical genetics\| PubMed ID: 25604082	2015
Phosphorylation of eIF2α triggered by mTORC1 inhibition and PP6C activation is required for autophagy and is aberrant in PP6C-mutated melanoma. Science signaling\| PubMed ID: 25759478	2015
Sensitivity of plasma BRAFmutant and NRASmutant cell-free DNA assays to detect metastatic melanoma in patients with low RECIST scores and non-RECIST disease progression. Molecular oncology\| PubMed ID: 26440707	2016
Identification of a Novel Pathogenic Germline KDR Variant in Melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 26631613	2016
The Expression Quantitative Trait Loci in Immune Pathways and their Effect on Cutaneous Melanoma Prognosis. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 26733611	2016
Pathways for Modulating Exosome Lipids Identified By High-Density Lipoprotein-Like Nanoparticle Binding to Scavenger Receptor Type B-1. Scientific reports\| PubMed ID: 26964503	2016
De Novo vs Nevus-Associated Melanomas: Differences in Associations With Prognostic Indicators and Survival. Journal of the National Cancer Institute\| PubMed ID: 27235387	2016
Constitutive Lck Activity Drives Sensitivity Differences between CD8+ Memory T Cell Subsets. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 27271569	2016
Genetic markers of pigmentation are novel risk loci for uveal melanoma. Scientific reports\| PubMed ID: 27499155	2016
Outcomes in Melanoma Patients Treated with BRAF/MEK-Directed Therapy or Immune Checkpoint Inhibition Stratified by Clinical Trial versus Standard of Care. Oncology\| PubMed ID: 28601879	2017
A Systems Biology Approach Identifies FUT8 as a Driver of Melanoma Metastasis. Cancer cell\| PubMed ID: 28609658	2017
Pre-metastatic cancer exosomes induce immune surveillance by patrolling monocytes at the metastatic niche. Nature communications\| PubMed ID: 29105655	2017
Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitors. Journal of translational medicine\| PubMed ID: 29606147	2018
Adjuvant NY-ESO-1 vaccine immunotherapy in high-risk resected melanoma: a retrospective cohort analysis. Journal for immunotherapy of cancer\| PubMed ID: 29773080	2018
Association between Ki-67 expression and clinical outcomes among patients with clinically node-negative, thick primary melanoma who underwent nodal staging. Journal of surgical oncology\| PubMed ID: 29878361	2018
Development of Novel Mutation-Specific Droplet Digital PCR Assays Detecting TERT Promoter Mutations in Tumor and Plasma Samples. The Journal of molecular diagnostics : JMD\| PubMed ID: 30827467	2019
Autoimmune genetic risk variants as germline biomarkers of response to melanoma immune-checkpoint inhibition. Cancer immunology, immunotherapy : CII\| PubMed ID: 30863922	2019
Impact of initial stage on metastatic melanoma survival. Melanoma research\| PubMed ID: 31026246	2019
Immunomodulatory germline variation associated with the development of multiple primary melanoma (MPM). Scientific reports\| PubMed ID: 31308438	2019
The complex relationship between body mass index and response to immune checkpoint inhibition in metastatic melanoma patients. Journal for immunotherapy of cancer\| PubMed ID: 31426863	2019
Relating the gut metagenome and metatranscriptome to immunotherapy responses in melanoma patients. Genome medicine\| PubMed ID: 31597568	2019
Functional analysis of RPS27 mutations and expression in melanoma. Pigment cell & melanoma research\| PubMed ID: 31663663	2020
Melanoma Prognosis: Accuracy of the American Joint Committee on Cancer Staging Manual Eighth Edition. Journal of the National Cancer Institute\| PubMed ID: 31977051	2020
TERT, BRAF, and NRAS Mutational Heterogeneity between Paired Primary and Metastatic Melanoma Tumors. The Journal of investigative dermatology\| PubMed ID: 32087194	2020
The urgency of utilizing COVID-19 biospecimens for research in the heart of the global pandemic. Journal of translational medicine\| PubMed ID: 32487093	2020
Preliminary analysis of distinct clinical and biologic features of bone metastases in melanoma. Melanoma research\| PubMed ID: 32804707	2020
Revisiting the association between skin toxicity and better response in advanced cancer patients treated with immune checkpoint inhibitors. Journal of translational medicine\| PubMed ID: 33176813	2020
Using Machine Learning Algorithms to Predict Immunotherapy Response in Patients with Advanced Melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 33208341	2021
Baseline prognostic nutritional index and changes in pretreatment body mass index associate with immunotherapy response in patients with advanced cancer. Journal for immunotherapy of cancer\| PubMed ID: 33219093	2020
Treatment with therapeutic anticoagulation is not associated with immunotherapy response in advanced cancer patients. Journal of translational medicine\| PubMed ID: 33516263	2021
Tumor immunogenomic signatures improve a prognostic model of melanoma survival. Journal of translational medicine\| PubMed ID: 33596955	2021
Chronic Immune-Related Adverse Events Following Adjuvant Anti-PD-1 Therapy for High-risk Resected Melanoma. JAMA oncology\| PubMed ID: 33764387	2021
The "Great Debate" at Melanoma Bridge 2020: December, 5th, 2020. Journal of translational medicine\| PubMed ID: 33827575	2021
Correction to: The urgency of utilizing COVID-19 biospecimens for research in the heart of the global pandemic. Journal of translational medicine\| PubMed ID: 34082754	2021
Targeting the Atf7ip-Setdb1 Complex Augments Antitumor Immunity by Boosting Tumor Immunogenicity. Cancer immunology research\| PubMed ID: 34462284	2021
Bacteroides vulgatus and Bacteroides dorei predict immune-related adverse events in immune checkpoint blockade treatment of metastatic melanoma. Genome medicine\| PubMed ID: 34641962	2021
Deep Learning and Pathomics Analyses Reveal Cell Nuclei as Important Features for Mutation Prediction of BRAF-Mutated Melanomas. The Journal of investigative dermatology\| PubMed ID: 34757067	2021
The histone demethylase PHF8 regulates TGFβ signaling and promotes melanoma metastasis. Science advances\| PubMed ID: 35179962	2022